SCHEMBL5597595

SCHEMBL5597595

Cc1cccc(C)c1NC(=O)Nc1cc(C2CC2)n[nH]1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.43
LMNA P02545 1/20 0.41
MAPT P10636 1/20 0.41
ALOX15 P16050 1/20 0.41
HTT P42858 1/20 0.41
RAB9A P51151 1/20 0.41
HSD17B10 Q99714 1/20 0.41
PYGL P06737 1/20 0.40
DRD4 P21917 3/20 0.40
POLB P06746 1/20 0.40
DRD2 P14416 1/20 0.39
HTR2A P28223 1/20 0.39
HTR2B P41595 1/20 0.39
ALDH1A1 P00352 2/20 0.39
PAK1 Q13153 1/20 0.39
KMT2A Q03164 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
PKM P14618 1/20 0.38
KCNJ6 P48051 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5597749 0.86 NPC1 (0.46) MAPTRAB9AL3MBTL1ACRIDH1
SCHEMBL5597514 0.81 TRPV1 (0.44) LMNAMAPTHTTPYGLALDH1A1
SCHEMBL5597942 0.80 TP53 (0.47) EPHX1SMN1; SMN2LMNAMAPTHTT
SCHEMBL5597625 0.80 RAB9A (0.46) SMN1; SMN2MAPTHTTRAB9AALDH1A1
SCHEMBL5867690 0.80 CRACR2A (0.52) SMN1; SMN2ALOX15HTTRAB9APOLB
SCHEMBL5597734 0.79 ALDH1A1 (0.41) SMN1; SMN2HTTRAB9APOLBALDH1A1
SCHEMBL5597878 0.79 MEN1 (0.53) SMN1; SMN2MAPTALOX15HTTRAB9A
SCHEMBL5597817 0.79 MEN1 (0.43) LMNAMAPTRAB9APOLBKMT2A
SCHEMBL5597907 0.79 DDX3X (0.57) SMN1; SMN2LMNAMAPTHTTALDH1A1
SCHEMBL5597681 0.77 TP53 (0.54) SMN1; SMN2LMNAMAPTHTTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1202734-B1 3(5)-UREIDO-PYRAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR AGENTS PFIZER ITALIA SRL (IT) 2007-05-02 EP claimed
EP-1202734-A4 3(5)-UREIDO-PYRAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2004-09-01 EP claimed
JP-2003507328-A 2003-02-25 JP claimed
US-6387900-B1 ANTICANCER AGENTS PHARMACIA & UPJOHN S.P.A. (IT) 2002-05-14 US claimed
EP-1202734-A1 3(5)-UREIDO-PYRAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR AGENTS Pharmacia Italia S.p.A. (IT) 2002-05-08 EP claimed
WO-2001012188-A1 3(5)-UREIDO-PYRAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR AGENTS PHARMACIA & UPJOHN S.P.A. (IT) 2001-02-22 WO claimed
EP-1202734-B1 3(5)-UREIDO-PYRAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR AGENTS PFIZER ITALIA SRL (IT) 2007-05-02 EP disclosed
US-6387900-B1 ANTICANCER AGENTS PHARMACIA & UPJOHN S.P.A. (IT) 2002-05-14 US disclosed